BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27446945)

  • 1. Classification of Non-Small Cell Lung Cancer Using Significance Analysis of Microarray-Gene Set Reduction Algorithm.
    Zhang L; Wang L; Du B; Wang T; Tian P; Tian S
    Biomed Res Int; 2016; 2016():2491671. PubMed ID: 27446945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test on existence of histology subtype-specific prognostic signatures among early stage lung adenocarcinoma and squamous cell carcinoma patients using a Cox-model based filter.
    Tian S; Wang C; An MW
    Biol Direct; 2015 Apr; 10():15. PubMed ID: 25887039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
    Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
    Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of monotonically differentially expressed genes for non-small cell lung cancer.
    Tian S
    BMC Bioinformatics; 2019 Apr; 20(1):177. PubMed ID: 30971213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico comparative genomic analysis of two non-small cell lung cancer subtypes and their potentials for cancer classification.
    Li J; Li D; Wei X; Su Y
    Cancer Genomics Proteomics; 2014; 11(6):303-10. PubMed ID: 25422361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighted-SAMGSR: combining significance analysis of microarray-gene set reduction algorithm with pathway topology-based weights to select relevant genes.
    Tian S; Chang HH; Wang C
    Biol Direct; 2016 Sep; 11(1):50. PubMed ID: 27681389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
    Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
    Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes.
    Kuner R; Muley T; Meister M; Ruschhaupt M; Buness A; Xu EC; Schnabel P; Warth A; Poustka A; Sültmann H; Hoffmann H
    Lung Cancer; 2009 Jan; 63(1):32-8. PubMed ID: 18486272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of gene expression profiles of lung cancer subtypes with machine learning algorithms.
    Yuan F; Lu L; Zou Q
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165822. PubMed ID: 32360590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies.
    Charkiewicz R; Pilz L; Sulewska A; Kozlowski M; Niklinska W; Moniuszko M; Reszec J; Manegold C; Niklinski J
    Int J Cancer; 2016 Feb; 138(3):689-97. PubMed ID: 26311306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes.
    Young GD; Winokur TS; Cerfolio RJ; Van Tine BA; Chow LT; Okoh V; Garver RI
    Lung Cancer; 2002 May; 36(2):133-41. PubMed ID: 11955647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification and survival prediction for early-stage lung adenocarcinoma and squamous cell carcinoma patients.
    Tian S
    Oncol Lett; 2017 Nov; 14(5):5464-5470. PubMed ID: 29098036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of non-small-cell lung cancer.
    Lacroix L; Commo F; Soria JC
    Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma.
    Toh SH; Prathipati P; Motakis E; Kwoh CK; Yenamandra SP; Kuznetsov VA
    BMC Genomics; 2011 Nov; 12 Suppl 3(Suppl 3):S24. PubMed ID: 22369099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-based gene expression signatures in non-small cell lung cancer.
    Zander T; Hofmann A; Staratschek-Jox A; Classen S; Debey-Pascher S; Maisel D; Ansén S; Hahn M; Beyer M; Thomas RK; Gathof B; Mauch C; Delank KS; Engel-Riedel W; Wichmann HE; Stoelben E; Schultze JL; Wolf J
    Clin Cancer Res; 2011 May; 17(10):3360-7. PubMed ID: 21558400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patients.
    Wu J; Zhou L; Huang L; Gu J; Li S; Liu B; Feng J; Zhou Y
    J Exp Clin Cancer Res; 2017 Jan; 36(1):4. PubMed ID: 28057025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers.
    Rohrbeck A; Neukirchen J; Rosskopf M; Pardillos GG; Geddert H; Schwalen A; Gabbert HE; von Haeseler A; Pitschke G; Schott M; Kronenwett R; Haas R; Rohr UP
    J Transl Med; 2008 Nov; 6():69. PubMed ID: 18992152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.
    Girard L; Rodriguez-Canales J; Behrens C; Thompson DM; Botros IW; Tang H; Xie Y; Rekhtman N; Travis WD; Wistuba II; Minna JD; Gazdar AF
    Clin Cancer Res; 2016 Oct; 22(19):4880-4889. PubMed ID: 27354471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes.
    Yang J; Lin J; Liu T; Chen T; Pan S; Huang W; Li S
    Lung Cancer; 2014 Aug; 85(2):110-5. PubMed ID: 24906504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.